+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Diagnostics Market - Global Forecast 2026-2032- Product Image
Clinical Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Clinical Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715761
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The clinical diagnostics market is entering a transformative phase as stakeholders adjust strategies amid rapid technological convergence, advanced automation, and evolving care delivery models. Senior executives face critical planning decisions as digital integration and workflow shifts create new priorities across the value chain.

Market Snapshot

The Clinical Diagnostics Market grew from USD 91.68 billion in 2025 to USD 98.68 billion in 2026. It is expected to continue rising at a CAGR of 8.89%, reaching USD 166.44 billion by 2032. Growing demand for decentralized testing, integrated informatics, and improved analytical solutions is shaping product investment and commercialization approaches across all global regions.

Scope & Segmentation

This research delivers a comprehensive, actionable view of the clinical diagnostics sector with focus on shifting business models, technological platforms, and regional expansion strategies. Market coverage includes:

  • Product Categories: Instruments, reagents, and software & services each demand unique innovation—ranging from analyzer and reagent improvements to advancements in diagnostic software and workflow integration.
  • Technologies: Clinical chemistry, hematology, immunoassay, and molecular diagnostics drive adoption. This includes platforms such as PCR, NGS, isothermal amplification methods, as well as CLIA/ELISA immunoassays.
  • Applications: Key application areas are cardiac care, diabetes management, genetic testing, infectious disease, and oncology—each requiring precise performance attributes and tailored reporting.
  • End Users: The sector serves academic institutions, diagnostic laboratories, hospital labs, home care, and point-of-care settings. Home settings emphasize self-testing, while critical/urgent care points demand robust and rapid systems with streamlined workflows.
  • Sample Types: Blood derivatives, saliva, urine, as well as tissue biopsies, define product logistics and design, affecting workflow requirements and analytical reliability.
  • Regions: The market encompasses the Americas, Europe, Middle East & Africa, and Asia-Pacific—each with distinct procurement models, regulatory frameworks, and care infrastructure development trajectories.

Key Takeaways

  • Technological convergence is reshaping lab operations, with automation and informatics integration now as influential as legacy instrument performance when evaluating new solutions.
  • Adoption of decentralized and point-of-care testing is accelerating, driving innovation in modular, easy-to-maintain platforms, particularly for remote and home-based diagnostics.
  • Regulatory scrutiny is prompting earlier collaboration between product and compliance teams, especially as AI and digital diagnostic components become routine parts of product offerings.
  • Market access success increasingly depends on regional customization—modular products and adaptable service packages are essential to meet diverse infrastructure and procurement needs.
  • Partnerships across diagnostics—linking specialized innovators with established supply chains and informatics partners—are opening new commercialization pathways and ensuring supply continuity.
  • Customer-centric service models, enhanced training, and support programs are proven differentiators as organizations compete on operational resilience and quality of service delivery.

Tariff Impact

Recent tariff-driven supply chain adjustments have pushed manufacturers to diversify suppliers and nearshore key manufacturing functions. These shifts are influencing procurement cycles, inventory strategies, and operational continuity planning for clinical diagnostics providers. Laboratories and hospitals increasingly rely on long-term supplier agreements, validation of interchangeable reagents, and adoption of vendor-managed inventory to minimize disruption risk. These adaptations are expected to influence future product validation and regional regulatory filings.

Methodology & Data Sources

This report is based on a rigorous mixed-methods approach, combining expert interviews, literature reviews, regulatory analysis, and direct engagement with clinical stakeholders. Data and insights are triangulated from instrument development specialists, laboratory operations leaders, regulatory filings, and procurement teams to ensure accuracy and relevance across markets and technologies.

Why This Report Matters

  • Offers clarity on next-generation diagnostic investment, enabling leadership to align capital planning with new technology trends and workflow requirements.
  • Supports risk-mitigated supply chain repositioning, evidenced by detailed analysis of tariff impacts and sourcing diversification.
  • Enhances strategic product development by synthesizing segmentation data, competitive dynamics, and regulatory pathways for targeted growth.

Conclusion

Technology-led innovation and strategic operational alignment are redefining the clinical diagnostics landscape. Leaders who act swiftly to enhance product modularity, deepen digital integration, and strengthen partnerships will be well positioned to address evolving market requirements and achieve sustainable growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Clinical Diagnostics Market, by Product Type
8.1. Instruments
8.1.1. Clinical Chemistry Analyzers
8.1.2. Hematology Analyzers
8.1.3. Immunoassay Analyzers
8.1.4. Molecular Diagnostics Instruments
8.2. Reagents
8.2.1. Clinical Chemistry Reagents
8.2.2. Hematology Reagents
8.2.3. Immunoassay Reagents
8.2.4. Molecular Diagnostics Reagents
8.3. Software & Services
8.3.1. Consultation & Support
8.3.2. Diagnostic Software
8.3.3. Lab Informatics
9. Clinical Diagnostics Market, by Technology
9.1. Clinical Chemistry
9.1.1. Electrochemical Assays
9.1.2. Photometric Assays
9.2. Hematology
9.2.1. Cbc Analyzers
9.2.2. Coagulation Analyzers
9.3. Immunoassay
9.3.1. Clia
9.3.2. Elisa
9.3.3. Fia
9.4. Molecular Diagnostics
9.4.1. Isothermal Amplification
9.4.2. Next Generation Sequencing
9.4.3. Pcr
10. Clinical Diagnostics Market, by Sample Type
10.1. Blood
10.1.1. Plasma
10.1.2. Serum
10.1.3. Whole Blood
10.2. Saliva
10.3. Tissue
10.3.1. Biopsy
10.3.2. Cytology
10.4. Urine
11. Clinical Diagnostics Market, by Application
11.1. Cardiac Care
11.1.1. Lipid Profile
11.1.2. Troponin Testing
11.2. Diabetes
11.2.1. Glucose Monitoring
11.2.2. Hba1c Testing
11.3. Genetic Testing
11.3.1. Hereditary Disease Testing
11.3.2. Prenatal Newborn Screening
11.4. Infectious Diseases
11.4.1. Hepatitis
11.4.2. Hiv
11.4.3. Influenza
11.4.4. Malaria
11.5. Oncology
11.5.1. Biomarker Testing
11.5.2. Minimal Residual Disease
11.5.3. Tumor Profiling
12. Clinical Diagnostics Market, by End User
12.1. Academic Research Institutes
12.2. Diagnostic Laboratories
12.3. Home Care
12.4. Hospital Laboratories
12.5. Point Of Care Testing
12.5.1. Clinics
12.5.2. Emergency Critical Care
13. Clinical Diagnostics Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Clinical Diagnostics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Clinical Diagnostics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Clinical Diagnostics Market
17. China Clinical Diagnostics Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Agilent Technologies, Inc.
18.7. Alere Inc.
18.8. Beckman Coulter, Inc.
18.9. Becton, Dickinson and Company
18.10. Bio-Rad Laboratories, Inc.
18.11. bioMérieux S.A.
18.12. Cepheid, Inc.
18.13. Danaher Corporation
18.14. DiaSorin S.p.A.
18.15. Genomic Health, Inc.
18.16. Grifols, S.A.
18.17. Hologic, Inc.
18.18. Illumina, Inc.
18.19. Luminex Corporation
18.20. PerkinElmer, Inc.
18.21. Qiagen N.V.
18.22. QuidelOrtho Corporation
18.23. Randox Laboratories Ltd.
18.24. Roche Diagnostics GmbH
18.25. Siemens Healthineers AG
18.26. Sysmex Corporation
18.27. Thermo Fisher Scientific Inc.
18.28. WerfenLife, S.A.
List of Figures
FIGURE 1. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CLINICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CLINICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CONSULTATION & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CONSULTATION & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CONSULTATION & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LAB INFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LAB INFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LAB INFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELECTROCHEMICAL ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELECTROCHEMICAL ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELECTROCHEMICAL ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PHOTOMETRIC ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PHOTOMETRIC ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PHOTOMETRIC ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CBC ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CBC ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CBC ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COAGULATION ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COAGULATION ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COAGULATION ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY FIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY FIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY FIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TROPONIN TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TROPONIN TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TROPONIN TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HBA1C TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HBA1C TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HBA1C TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEREDITARY DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEREDITARY DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEREDITARY DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRENATAL NEWBORN SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRENATAL NEWBORN SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRENATAL NEWBORN SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEPATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HIV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HIV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MALARIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MALARIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MALARIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY EMERGENCY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY EMERGENCY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY EMERGENCY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 218. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 219. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 220. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 221. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 222. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2032 (USD MILLION)
TABLE 224. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 225. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 226. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 227. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 228. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 248. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 249. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. NORTH AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 262. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 264. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2032 (USD MILLION)
TABLE 266. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 267. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 268. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 269. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 270. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. LATIN AMERICA CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2032 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
TABLE 293. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 294. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 295. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 296. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 297. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 298. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 299. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 300. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 301. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 302. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 303. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 304. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 305. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
TABLE 306. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2032 (USD MILLION)
TABLE 308. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 309. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 310. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 311. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 312. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 313. EUROPE CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
TABLE 314. MIDDLE EAST CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 315. MIDDLE EAST CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 316. MIDDLE EAST CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 317. MIDDLE EAST CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENT

Companies Mentioned

The key companies profiled in this Clinical Diagnostics market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Cepheid, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Genomic Health, Inc.
  • Grifols, S.A.
  • Hologic, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Roche Diagnostics GmbH
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • WerfenLife, S.A.

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 98.68 Billion
Forecasted Market Value ( USD ) by 2032 $ 166.44 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Clinical Diagnostic DNA Extractor Market - Global Forecast to 2030 - Product Image

Clinical Diagnostic DNA Extractor Market - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Clinical Diagnostics Market Size, Share, Trends and Forecast by Test, Product, End User, and Region, 2025-2033 - Product Image

Clinical Diagnostics Market Size, Share, Trends and Forecast by Test, Product, End User, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From
Clinical Diagnostics Market Report 2025 - Product Image

Clinical Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Lab Automation In Clinical Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Lab Automation In Clinical Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Clinical Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Clinical Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 189 Pages
  • Global
From

About the Clinical Diagnostic Market

The Clinical Diagnostics market is a segment of the Diagnostics industry that focuses on the diagnosis and treatment of diseases and medical conditions. It includes a wide range of tests and procedures used to detect, diagnose, and monitor diseases and medical conditions. These tests are used to identify the presence of a disease or condition, to determine the cause of a disease or condition, and to monitor the progress of a disease or condition. Clinical Diagnostics tests are used to diagnose and monitor a variety of diseases and medical conditions, including cancer, cardiovascular disease, infectious diseases, and genetic disorders. The Clinical Diagnostics market is highly competitive, with a number of companies offering a wide range of products and services. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.